LTRN
Lantern Pharma Inc.
$4.08
+$0.02(+0.49%)
46
Overall
--
Value
72
Tech
21
Quality
Market Cap
$47.41M
Volume
72.87K
52W Range
$2.55 - $6.12
Target Price
$25.50
EPS Estimates Overview
| Current Quarter | $-0.44 | Next Quarter | $-0.43 |
| Current Year | $-1.81 | Next Year | $-1.14 |
| QoQ Growth | +2.3% | YoY Growth | +37.0% |
| 3Y EPS CAGR | N/A | Target Price | $25.50 |
| Consensus | Buy | Upside | +525.0% |
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LTRN | $4.08 | +0.5% | 72.87K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |